Research Library

Body-Weight Findings in Retatrutide Trials

Trials of Lilly’s investigated LY3437943 have reported some of the largest mean body-weight changes in randomized metabolic research. These results are a major reason for scientific interest in the...

Retatrutide Full Evidence Review

Retatrutide has a well-defined molecular and receptor-pharmacology record, substantial randomized evidence for weight and glycemic endpoints, and a large ongoing clinical program. Evidence strength...

Retatrutide: Complete Research Overview

LY3437943, the investigational molecule developed by Eli Lilly and commonly known as retatrutide, has become one of the most closely watched subjects in current metabolic research. It was designed ...

TB-500 Full Evidence Review

The strongest direct evidence for TB-500 concerns molecular identity and analytical detection, not completed human outcomes. Esposito et al. identified and synthesized Ac-LKKTETQ from a seized prod...

TB-500 Research Overview

The best-supported product-specific definition of TB-500 is an N-terminally acetylated seven-amino-acid peptide: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH, abbreviated Ac-LKKTETQ. It corresponds to residue...

Ipamorelin Full Evidence Review

Ipamorelin, development code NNC 26-0161, is a synthetic amidated pentapeptide with sequence Aib–His–D-2-Nal–D-Phe–Lys–NH₂. It is a functional agonist of the ghrelin/growth-hormone-secretagogue rec...

Ipamorelin Research Overview

Ipamorelin, development code NNC 26-0161, is a synthetic amidated pentapeptide developed within Novo Nordisk’s growth-hormone-secretagogue research program. Its sequence is Aib–His–D-2-Nal–D-Phe–Ly...

CJC-1295 Without DAC: Full Evidence Review

Looking for the shorter version? Start with the CJC-1295 Without DAC Research Overview.

CJC-1295 Without DAC Research Overview

CJC-1295 without DAC is a common name for a synthetic 29-amino-acid analogue of the active N-terminal portion of human growth hormone–releasing hormone (GHRH). The most precise description is [D-Al...

BPC-157 Full Evidence Review

BPC-157 is a chemically synthesized linear 15-amino-acid peptide, GEPPPGKPADDAGLV, commonly described as a stable gastric pentadecapeptide. Its synthetic identity is established; its frequently cla...